TrizAural Ear Flush

TrizAural is a specialized veterinary product designed as an alkaline, aqueous ear flush for dogs and cats. It is primarily used to assist in the management of ear infections and maintaining ear hygiene in pets. The product is formulated to be non-irritating, utilizing a buffered formula that supports antibiotic treatment by destabilizing bacterial cell walls.

The brand is part of the Dechra Pharmaceuticals portfolio, a major player in the global veterinary medicine market. Originally a British brand, it has grown through strategic acquisitions and global distribution channels. While Dechra maintains significant manufacturing footprints in the UK and Europe, its ownership structure shifted in 2024 when it was acquired by the private equity firm EQT, transitioning it from a publicly traded entity on the London Stock Exchange to private ownership.